Staphylococcal protein A inhibits complement activation by interfering with IgG hexamer formation

Ana Rita Cruz(Utrecht University), Maurits A. den Boer(Utrecht University), Jürgen Strasser(University of Applied Sciences Upper Austria), Seline A. Zwarthoff(Utrecht University), Frank J. Beurskens(Genmab (Netherlands)), Carla J. C. de Haas(Utrecht University), Piet C. Aerts(Utrecht University), Guanbo Wang(Nanjing Normal University), Rob N. de Jong(Genmab (Netherlands)), Fábio Bagnoli(GlaxoSmithKline (Italy)), Jos A. G. van Strijp(Utrecht University), Kok P. M. van Kessel(Utrecht University), Janine Schuurman(Genmab (Netherlands)), Johannes Preiner(University of Applied Sciences Upper Austria), Albert J. R. Heck(Utrecht University), Suzan H. M. Rooijakkers(Utrecht University)
Proceedings of the National Academy of Sciences
February 9, 2021
Cited by 110Open Access
Full Text

Abstract

Significance Antibodies are crucial for the immune response against bacteria. To drive bacterial killing, antibodies should bind to the bacterial cell and induce the complement reaction. This requires target-bound IgGs to form hexameric IgG platforms that are kept together by noncovalent Fc-Fc interactions. Interestingly, pathogenic bacteria produce IgG-binding molecules that bind specifically to the Fc region needed for hexamerization. Here we demonstrate that staphylococcal protein A (SpA) from Staphylococcus aureus specifically blocks formation of IgG hexamers and downstream activation of complement. Furthermore, we show that IgG3 antibodies (which are not recognized by SpA) have superior capacity to activate complement and induce killing of S. aureus by human phagocytes. These insights provide a crucial rationale for optimizing antibody therapies against S. aureus .


Related Papers

No related papers found

Powered by citation graph analysis